Benzinga | Jul 29, 2020 12:25PM EDT

Piper Sandler Maintains Overweight on DexCom, Raises Price Target to $465

Piper Sandler maintains DexCom (NASDAQ:DXCM) with a Overweight and raises the price target from $450 to $465.